Download A4Medicine Mobile App

Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀

A4Medicine

Allergic Reactions and Triage in Primary Care : Introduction

Allergic reactions represent a complex interplay between the immune system and environmental antigens, leading to a spectrum of clinical manifestations. These reactions are primarily classified into four types based on the Gell-Coombs classification, with Type I hypersensitivity being the most common. This immediate response is mediated by immunoglobulin E (IgE) antibodies and can result in acute conditions such as anaphylaxis—a life-threatening systemic reaction—as well as chronic conditions like allergic asthma and atopic dermatitis (Voisin et al., 2017; Ab, 2018; Kotb, 2022). The underlying pathophysiology involves the activation of mast cells and basophils, which release inflammatory mediators such as histamine, leukotrienes, and cytokines, thereby producing the clinical symptoms observed in allergic individuals (Durrani et al., 2024; López‐Sanz et al., 2021; Radtke & Voehringer, 2023).



Types of Allergic Reactions

Type Mechanism Onset Key Mediators/Cells Clinical Examples
Type I IgE-mediated immediate reaction Minutes IgE, mast cells, histamine ↑, leukotrienes, cytokines Anaphylaxis, allergic rhinitis, asthma, atopic dermatitis
Type II Antibody-mediated cytotoxic reaction Hours–Days IgG/IgM, complement activation, opsonization Hemolytic anemia, Goodpasture syndrome, some drug reactions
Type III Immune complex-mediated reaction Hours–Days Immune complexes, complement, neutrophils Serum sickness, Arthus reaction, certain autoimmune conditions
Type IV T-cell mediated delayed reaction 48–72 hours T lymphocytes, macrophages Contact dermatitis, tuberculin reaction, chronic transplant rejection



In the primary care setting, effective triage is essential for the prompt identification and management of allergic reactions. Given that all our transactions—both clinical and administrative—are streamlined through a single point of care, primary care providers must be adept at distinguishing between reactions that necessitate urgent intervention and those that can be managed in an outpatient environment. The sensitization phase of an allergic reaction begins when the immune system is first exposed to an allergen, leading to the production of allergen-specific IgE antibodies. Upon re-exposure, these antibodies trigger the degranulation of mast cells and basophils, releasing inflammatory mediators that cause symptoms such as itching, swelling, and bronchoconstriction (Ab, 2018; Salazar & Ghaemmaghami, 2013; Sutanto, 2024). T-helper cells, particularly Th2 cells, play a pivotal role in orchestrating this immune response by promoting IgE production and recruiting additional immune cells to the site of allergen exposure (Kotb, 2022; Kudrin & Rebane, 2023).



1. Patient Demographics







Gender:










2. Symptoms

What symptoms are you experiencing?







2A. Symptom Onset


2B. Symptom Progression

Have the symptoms:




3. Allergen Exposure

Have you been exposed to any known allergens?





3A. Previous Reactions

Have you had a similar reaction before?






4. Breathing

Do you have difficulty breathing?


4A. Speech

Are you experiencing hoarseness or difficulty speaking?


4B. Swelling

Have you had swelling in your mouth, lips, tongue, or throat?


4C. Dizziness

Are you feeling lightheaded, dizzy, or faint?


4D. Heartbeat

Do you have a rapid or irregular heartbeat?


4E. Consciousness

Have you lost consciousness?




5. Provocation/Palliation

What makes the symptoms better or worse?

5A. Symptom Quality

Describe the nature of your symptoms (e.g., sharp pain, burning, tingling).

5B. Region/Radiation

Where are your symptoms located? Do they spread?

5C. Severity

On a scale of 1 to 10, how severe are your symptoms?

5D. Timing

Have the symptoms changed over time?



6. Allergy History

Do you have a history of allergies?


6A. Pre-existing Conditions

Have you been diagnosed with asthma, eczema, or other allergic conditions?


6B. Medications

Are you currently taking any medications, including antihistamines or epinephrine?





6C. Epinephrine Use

Have you previously needed an epinephrine injection (EpiPen) for an allergic reaction?




7. Impact on Daily Life

Are your symptoms affecting your ability to work, study, or perform daily activities?







8. Severity Assessment & Triage Scoring

Based on your symptoms, select the most applicable severity level:






9. Additional Information

Is there anything else you would like to add about your symptoms or concerns?



10. Healthcare Provider Assessment

Physical Examination Findings:

10A. Immediate Interventions

Interventions provided (if applicable):





10B. Follow-up Plan

Recommended follow-up action:







For primary care practitioners, understanding these mechanisms is crucial not only for accurate diagnosis but also for effective triage. Mild reactions, such as allergic rhinitis or urticaria, can often be managed conservatively, whereas severe reactions like anaphylaxis require immediate and aggressive treatment to prevent rapid progression to cardiovascular collapse or respiratory failure (SokoƂowska et al., 2021). Moreover, chronic allergic conditions such as asthma can lead to significant morbidity and potential long-term pulmonary damage if not adequately controlled (Voisin et al., 2017; O’Konek et al., 2019). The psychological impact of living with allergies—including anxiety and avoidance behaviors—further underscores the need for a comprehensive, patient-centered approach in primary care settings (Warrington et al., 2018; Palm et al., 2012).



  1. Ab, S. (2018). Allergen preparation and standardization: an updat. Global Journal of Otolaryngology, 17(4). https://doi.org/10.19080/gjo.2018.17.555968
  2. Brundha, M. (2020). Rast and eucast in blood test- a review. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v14i4.12411
  3. Durrani, M., Ayub, F., Mujahid, M., Khan, M., Samiullah, H., Shujait, M., 
 & Altaf, I. (2024). The microbial role in allergy: a comprehensive review. JHRR, 4(1), 1652-1660. https://doi.org/10.61919/jhrr.v4i1.660
  4. Kudrin, P. and Rebane, A. (2023). Do rna modifications contribute to modulation of immune responses in allergic diseases?. Frontiers in Allergy, 4. https://doi.org/10.3389/falgy.2023.1277244
  5. LĂłpez‐Sanz, C., JimĂ©nez‐Saiz, R., & Ehlers, A. (2021). Local inflammation enables a basophil‐neuronal circuitch in atopic dermatitis. Allergy, 77(2), 708-710. https://doi.org/10.1111/all.15026
  6. O’Konek, J., Landers, J., Janczak, K., Lindsey, H., Mondrusov, A., Totten, T., 
 & Baker, J. (2019). Intranasal nanoemulsion vaccine confers long‐lasting immunomodulation and sustained unresponsiveness in a murine model of milk allergy. Allergy, 75(4), 872-881. https://doi.org/10.1111/all.14064
  7. Palm, N., Rosenstein, R., & Medzhitov, R. (2012). Allergic host defences. Nature, 484(7395), 465-472. https://doi.org/10.1038/nature11047
  8. Radtke, D. and Voehringer, D. (2023). Granulocyte development, tissue recruitment, and function during allergic inflammation. European Journal of Immunology, 53(8). https://doi.org/10.1002/eji.202249977
  9. Salazar, F. and Ghaemmaghami, A. (2013). Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Frontiers in Immunology, 4. https://doi.org/10.3389/fimmu.2013.00356
  10. SokoƂowska, M., Eiwegger, T., Ollert, M., Torres, M., Barber, D., Giacco, S., 
 & Shamji, M. (2021). Eaaci statement on the diagnosis, management and prevention of severe allergic reactions to covid‐19 vaccines. Allergy, 76(6), 1629-1639. https://doi.org/10.1111/all.14739
  11. Sutanto, H. (2024). Mechanobiology of type 1 hypersensitivity: elucidating the impacts of mechanical forces in allergic reactions.. https://doi.org/10.22541/au.170863914.41137652/v1
  12. Voisin, T., Bouvier, A., & Chiu, I. (2017). Neuro-immune interactions in allergic diseases: novel targets for therapeutics. International Immunology, 29(6), 247-261. https://doi.org/10.1093/intimm/dxx040
  13. Warrington, R., Silviu-Dan, F., & Wong, T. (2018). Drug allergy. Allergy Asthma & Clinical Immunology, 14(S2). https://doi.org/10.1186/s13223-018-0289-y
  14. kotb, s. (2022). Allergic reaction : etiology , pathogenesis with advanced vision in therapeutics modalities.. https://doi.org/10.31219/osf.io/w356q